annual CAPEX:
$36.21M-$6.05M(-14.31%)Summary
- As of today (September 16, 2025), TVTX annual capital expenditures is $36.21 million, with the most recent change of -$6.05 million (-14.31%) on December 31, 2024.
- During the last 3 years, TVTX annual CAPEX has risen by +$12.06 million (+49.94%).
- TVTX annual CAPEX is now -14.31% below its all-time high of $42.26 million, reached on December 31, 2023.
Performance
TVTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$12.32M+$537.00K(+4.56%)Summary
- As of today (September 16, 2025), TVTX quarterly capital expenditures is $12.32 million, with the most recent change of +$537.00 thousand (+4.56%) on June 30, 2025.
- Over the past year, TVTX quarterly CAPEX has increased by +$328.00 thousand (+2.73%).
- TVTX quarterly CAPEX is now -55.94% below its all-time high of $27.97 million, reached on March 31, 2023.
Performance
TVTX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$41.86M+$328.00K(+0.79%)Summary
- As of today (September 16, 2025), TVTX TTM capital expenditures is $41.86 million, with the most recent change of +$328.00 thousand (+0.79%) on June 30, 2025.
- Over the past year, TVTX TTM CAPEX has increased by +$12.94 million (+44.76%).
- TVTX TTM CAPEX is now -18.34% below its all-time high of $51.26 million, reached on March 31, 2023.
Performance
TVTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TVTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | +2.7% | +44.8% |
| 3 y3 years | +49.9% | +7.5% | +53.3% |
| 5 y5 years | +132.7% | +177.8% | +142.7% |
TVTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.3% | +49.9% | -55.9% | +221.2% | -18.3% | +101.7% |
| 5 y | 5-year | -14.3% | +132.7% | -55.9% | +221.2% | -18.3% | +142.7% |
| alltime | all time | -14.3% | >+9999.0% | -55.9% | >+9999.0% | -18.3% | >+9999.0% |
TVTX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $12.32M(+4.6%) | $41.86M(+0.8%) |
| Mar 2025 | - | $11.78M(+23.3%) | $41.53M(+14.7%) |
| Dec 2024 | $36.21M(-14.3%) | $9.56M(+16.7%) | $36.21M(+12.5%) |
| Sep 2024 | - | $8.19M(-31.7%) | $32.18M(+11.3%) |
| Jun 2024 | - | $11.99M(+85.5%) | $28.91M(+39.3%) |
| Mar 2024 | - | $6.47M(+16.9%) | $20.76M(-50.9%) |
| Dec 2023 | $42.26M(+48.0%) | $5.53M(+12.3%) | $42.26M(+3.3%) |
| Sep 2023 | - | $4.93M(+28.4%) | $40.93M(-6.2%) |
| Jun 2023 | - | $3.84M(-86.3%) | $43.63M(-14.9%) |
| Mar 2023 | - | $27.97M(+566.4%) | $51.26M(+79.5%) |
| Dec 2022 | $28.56M(+18.2%) | $4.20M(-45.0%) | $28.56M(-3.4%) |
| Sep 2022 | - | $7.63M(-33.4%) | $29.56M(+8.3%) |
| Jun 2022 | - | $11.46M(+117.6%) | $27.30M(+35.5%) |
| Mar 2022 | - | $5.27M(+1.3%) | $20.15M(-16.6%) |
| Dec 2021 | $24.15M(-1.7%) | $5.20M(-3.2%) | $24.15M(-12.3%) |
| Sep 2021 | - | $5.37M(+24.8%) | $27.55M(-5.3%) |
| Jun 2021 | - | $4.31M(-53.5%) | $29.09M(-0.4%) |
| Mar 2021 | - | $9.27M(+7.8%) | $29.22M(+19.0%) |
| Dec 2020 | $24.57M(+57.8%) | $8.60M(+24.4%) | $24.57M(+23.2%) |
| Sep 2020 | - | $6.92M(+55.9%) | $19.95M(+15.6%) |
| Jun 2020 | - | $4.44M(-3.9%) | $17.25M(+6.5%) |
| Mar 2020 | - | $4.61M(+15.9%) | $16.20M(+4.1%) |
| Dec 2019 | $15.56M(-21.0%) | $3.98M(-5.6%) | $15.56M(+0.7%) |
| Sep 2019 | - | $4.22M(+24.5%) | $15.45M(+2.5%) |
| Jun 2019 | - | $3.39M(-14.9%) | $15.08M(-2.2%) |
| Mar 2019 | - | $3.98M(+2.9%) | $15.43M(-21.7%) |
| Dec 2018 | $19.70M(+40.6%) | $3.87M(+0.5%) | $19.70M(+4.9%) |
| Sep 2018 | - | $3.85M(+3.0%) | $18.77M(+0.6%) |
| Jun 2018 | - | $3.73M(-54.8%) | $18.66M(+4.0%) |
| Mar 2018 | - | $8.26M(+180.8%) | $17.95M(+28.1%) |
| Dec 2017 | $14.01M | $2.94M(-21.3%) | $14.01M(-8.4%) |
| Sep 2017 | - | $3.73M(+23.7%) | $15.30M(+6.6%) |
| Jun 2017 | - | $3.02M(-30.0%) | $14.35M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $4.32M(+2.0%) | $13.64M(+14.4%) |
| Dec 2016 | $11.92M(+69.6%) | $4.23M(+51.8%) | $11.92M(+26.6%) |
| Sep 2016 | - | $2.79M(+20.9%) | $9.42M(-10.4%) |
| Jun 2016 | - | $2.31M(-11.3%) | $10.51M(+9.4%) |
| Mar 2016 | - | $2.60M(+50.8%) | $9.60M(+36.6%) |
| Dec 2015 | $7.03M(+77.3%) | $1.72M(-55.6%) | $7.03M(+30.5%) |
| Sep 2015 | - | $3.88M(+177.2%) | $5.39M(+223.7%) |
| Jun 2015 | - | $1.40M(+5546.0%) | $1.66M(-55.8%) |
| Mar 2015 | - | $24.80K(-69.5%) | $3.76M(-5.1%) |
| Dec 2014 | $3.96M(-28.6%) | $81.40K(-48.4%) | $3.96M(-51.1%) |
| Sep 2014 | - | $157.70K(-95.5%) | $8.10M(+1.8%) |
| Jun 2014 | - | $3.50M(+1437.4%) | $7.96M(+78.0%) |
| Mar 2014 | - | $227.50K(-94.6%) | $4.47M(-19.4%) |
| Dec 2013 | $5.55M(+365.2%) | $4.22M(>+9900.0%) | $5.55M(+317.9%) |
| Sep 2013 | - | $12.60K(+46.5%) | $1.33M(+1.0%) |
| Jun 2013 | - | $8600.00(-99.3%) | $1.32M(+0.7%) |
| Mar 2013 | - | $1.31M(>+9900.0%) | $1.31M(>+9900.0%) |
| Dec 2012 | $1.19M(>+9900.0%) | - | - |
| Nov 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2008 | - | $0.00 | $0.00 |
| Feb 2008 | $0.00 | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Travere Therapeutics, Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Travere Therapeutics, Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Travere Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of TVTX is $36.21M
What is the all time high annual CAPEX for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual capital expenditures is $42.26M
What is Travere Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, TVTX annual capital expenditures has changed by -$6.05M (-14.31%)
What is Travere Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of TVTX is $12.32M
What is the all time high quarterly CAPEX for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly capital expenditures is $27.97M
What is Travere Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, TVTX quarterly capital expenditures has changed by +$328.00K (+2.73%)
What is Travere Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of TVTX is $41.86M
What is the all time high TTM CAPEX for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM capital expenditures is $51.26M
What is Travere Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, TVTX TTM capital expenditures has changed by +$12.94M (+44.76%)